<p>Three psychedelic companies received vouchers for expedited FDA review: Usona, Compass Pathways, and Otsuka—NOT Resilient Pharmaceuticals. This voucher announcement is yet another vindication of our reporting on major problems and pseudoscience within Lykos'/Resilient's trials. Update to episode #68.</p>

Three psychedelic companies received vouchers for expedited FDA review: Usona, Compass Pathways, and Otsuka—NOT Resilient Pharmaceuticals. This voucher announcement is yet another vindication of our reporting on major problems and pseudoscience within Lykos'/Resilient's trials. Update to episode #68.

#68 UPDATE: A Leftist Primer to the Right-Wing Psychedelic Takeover

Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction. We offer critical perspectives on drugs, politics, and culture.


The podcast is co-hosted by Psymposia co-founder Brian Normand, psychedelics researcher and ethicist Neşe Devenot, evolutionary ecologist Brian Pace, and journalist Russell Hausfeld.

Society & Culture

Education

Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction. We offer critical perspectives on drugs, politics, and culture. The podcast is co-hosted by Psymposia co-founder Brian Normand, psychedelics researcher and ethicist Neşe Devenot, evolutionary ecologist Brian Pace, and journalist Russell Hausfeld.

Share #68 UPDATE: A Leftist Primer to the Right-Wing Psychedelic Takeover

Sign up to save your podcasts

#68 UPDATE: A Leftist Primer to the Right-Wing Psychedelic Takeover

#68 UPDATE: A Leftist Primer to the Right-Wing Psychedelic Takeover

More shows like The Psymposia Podcast

TRUE ANON TRUTH FEED